Cognition Therapeutics INC (CGTX) — 8-K Filings

All 8-K filings from Cognition Therapeutics INC. Browse 30 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (30)

COGNITION THERAPEUTICS Files 8-K on Financial Results — Mar 26, 2026
COGNITION THERAPEUTICS INC filed an 8-K on March 26, 2026, disclosing results of operations and financial condition under Item 2.02 and Regulation FD Disclosure
8-K Filing — Dec 18, 2025
8-K Filing — Sep 15, 2025
Cognition Therapeutics Enters Material Definitive Agreement — Aug 28, 2025 Risk: medium
Cognition Therapeutics, Inc. announced on August 27, 2025, that it entered into a material definitive agreement. The filing does not provide specific details ab
Cognition Therapeutics Files 8-K — Aug 26, 2025 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on August 26, 2025, reporting an event under "Other Events." The filing does not contain specific details about the ev
Cognition Therapeutics Files 8-K on Financials — Aug 7, 2025 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on August 7, 2025, reporting on its results of operations and financial condition, and including financial statements
Cognition Therapeutics Files 8-K on Shareholder Vote Matters — Jun 20, 2025 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on June 20, 2025, reporting on matters submitted to a vote of security holders as of June 18, 2025. The filing does no
Cognition Therapeutics Files 8-K — Jun 3, 2025 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on June 3, 2025, reporting other events and financial statements. The filing details the company's principal executive
8-K Filing — Jun 2, 2025
Cognition Therapeutics Files 8-K — May 8, 2025 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on May 8, 2025, reporting other events and financial statements. The filing does not contain specific financial figure
Cognition Therapeutics Files 8-K on Financials — May 7, 2025 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition, and including financial statements and
Cognition Therapeutics Files 8-K on Financials — Mar 20, 2025 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on March 20, 2025, reporting on its results of operations and financial condition. The filing also includes financial
Cognition Therapeutics Files 8-K — Mar 12, 2025 Risk: medium
Cognition Therapeutics, Inc. filed an 8-K on March 12, 2025, reporting other events. The filing does not contain specific details about the nature of these even
Cognition Therapeutics Files 8-K — Feb 26, 2025 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on February 26, 2025, reporting on other events and financial statements. The filing does not contain specific financi
Cognition Therapeutics Files 8-K — Jan 28, 2025 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on January 28, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific fi
Cognition Therapeutics Files 8-K — Jan 13, 2025 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not c
Cognition Therapeutics Files 8-K — Dec 18, 2024 Risk: medium
Cognition Therapeutics, Inc. filed an 8-K on December 18, 2024, to report other events and financial statements. The filing does not contain specific details ab
Cognition Therapeutics Files 8-K on Financials — Nov 13, 2024 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on November 13, 2024, reporting on its results of operations and financial condition, as well as financial statements
Cognition Therapeutics Files 8-K — Oct 1, 2024 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on October 1, 2024, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD di
Cognition Therapeutics Faces Delisting Concerns — Sep 13, 2024 Risk: high
Cognition Therapeutics, Inc. filed an 8-K on September 13, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company's p
Cognition Therapeutics Files 8-K — Aug 28, 2024 Risk: medium
Cognition Therapeutics, Inc. filed an 8-K on August 28, 2024, to report on financial statements and exhibits, and for a Regulation FD Disclosure. The filing doe
Cognition Therapeutics Files 8-K on Financials — Aug 8, 2024 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing includes financial state
Cognition Therapeutics Files 8-K — Jul 29, 2024 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on July 29, 2024, reporting other events and financial statements. The filing does not contain specific details on new
Cognition Therapeutics Files 8-K on Security Holder Votes — Jun 7, 2024 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on June 7, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specifi
Cognition Therapeutics Files 8-K on Financials — May 7, 2024 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on May 7, 2024, reporting on its results of operations and financial condition. The filing includes financial statemen
Cognition Therapeutics Files 8-K — Mar 26, 2024 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on March 26, 2024, reporting on its results of operations and financial condition, and including financial statements
Cognition Therapeutics Enters Material Definitive Agreement — Mar 13, 2024 Risk: medium
Cognition Therapeutics, Inc. announced on March 11, 2024, that it entered into a Material Definitive Agreement. The company, incorporated in Delaware with its p
Cognition Therapeutics Files 8-K — Mar 11, 2024 Risk: low
Cognition Therapeutics, Inc. filed an 8-K on March 11, 2024, reporting on its results of operations and financial condition. The filing does not contain specifi
Cognition Therapeutics Reports Officer Changes and Compensation Arrangements — Feb 20, 2024 Risk: medium
Cognition Therapeutics, Inc. filed an 8-K on February 20, 2024, reporting an event that occurred on February 15, 2024. The filing pertains to the departure or e
Cognition Therapeutics Files Routine 8-K on Jan 4, 2024 — Jan 4, 2024
Cognition Therapeutics, Inc. filed an 8-K on January 4, 2024, to report 'Other Events' and 'Financial Statements and Exhibits.' This filing is a routine update,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX